Navigating the FDA disruption: 4 key actions for pharma
Explore how pharma and biotech leaders can navigate FDA disruption with smarter submissions, regulatory agility, and global risk mitigation strategies.
Explore PwC’s Next in Health podcast series
Co-hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
Listen in to PwC Next in Health podcast conversations here or follow our series Apple Podcasts, Spotify, YouTube Music and more.
All Episodes
15 results
Loading...
Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma
Explore the rise of China’s biotech industry and what it means for U.S. pharma, from innovation and partnerships to diligence and global strategy.
Navigating Healthcare’s Next Chapter Under the Trump Administration
Explore how shifting policies, tariffs, AI, and regulatory changes are reshaping healthcare strategy, innovation, and affordability in 2025.
Next in Pharma: The 2025 Outlook—The Future is Now
Discover key insights from PwC's 2025 pharma outlook on AI innovation, patent cliffs, strategic resilience, and navigating global market disruptions.
Loading...
Other PwC podcast series
< Back
< Back
[+] Read More
Follow us
